Calcium-dependent Enhancement of Depletion-activated Calcium Current in Jurkat T Lymphocytes

E. Christian,K. Spence,J. Togo,P. Dargis,J. Patel

DOI: https://doi.org/10.1007/s002329900030

1996-03-01

Abstract:

What problem does this paper attempt to address?

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

Liya Ma,Hongyan Tong,Lingxiang Ruan,Zhiheng Ling,Yanling Ren,Xinping Zhou

DOI: https://doi.org/10.1016/j.idcr.2016.10.002

2016-01-01

IDCases

Abstract:The incidence of invasive candidal infection is increasing. The widespread use of central intravascular catheters, invasive procedures, immunosuppression, diabetes mellitus, total parenteral nutrition, broad-spectrum antibiotics and drugs abuse predispose patients to the infection. Eye, kidney, liver, skin, cardiac and brain infections are the most common site of invasive candidiasis while vertebral osteomyelitis is rare. Most Candida vertebral osteomyelitis is caused by Candida albicans. Less common organisms include C. tropicalis, C. glabrata and C. parapsilosis [1]. Both amphotericin B and the azoles have a role in the treatment, but treatment failure with either agent had been reported [2], [3]. Micafungin belongs to echinocandins, and interferes with the synthesis of fungal cell wall.We report a Candida tropicalis infection manifested with osteomyelitis following a previous candidemia in a leukemia patient who was successfully treated by Micafungin.
Fungus Ball and Emphysematous Cystitis Secondary to Candida Tropicalis: A Case Report

Lei Wang,Xiang Ji,Guo-feng Sun,Ying-chao Qin,Miao-zi Gong,Jin-xia Zhang,Ning-chen Li,Yan-qun Na

DOI: https://doi.org/10.5489/cuaj.3008

2015-01-01

Canadian Urological Association Journal

Abstract:Fungus ball and fungal emphysematous cystitis are two rare complications of fungal urinary tract infection. A 53-year-old male patient presented with these complications caused by Candida tropicalis simultaneously. The predisposing factors were diabetes mellitus and usage of broad-spectrum antibiotics. The fungus ball, measuring 3.5 × 2.0 cm on the left wall of the urinary bladder, shrank significantly to 1.6 × 0.8 cm after 5 days of intermittent irrigation with saline before surgery. With transurethral removal of the fungus ball and antifungal treatment with fluconazole, the patient fully recovered. We conclude that a bladder fungus ball and fungal emphysematous cystitis should always be suspected in patients with diabetes mellitus with uncontrolled funguria and abnormal imaging. Treatment should include a systemic antifungal therapy and thorough surgical removal of the fungus ball. A systemic antifungal therapy combined with a local irrigation with saline or antifungal drugs might help decrease the dissemination of fungemia during an invasive manipulation.
Adjunctive intravesical EDTA-tromethamine treatment of a biofilm-associated recurrent Escherichia coli cystitis in a dog

Vincent Leynaud,Nicolas P Jousserand,Marie-Noëlle Lucas,Laurent Cavalié,Jean-Paul Motta,Éric Oswald,Rachel Lavoué

Abstract:A 15-month-old spayed female greater Swiss mountain dog was brought to our clinic because of relapsing episodes of urinary tract infection, present since her adoption at 2 mo of age. A diagnosis of chronic bacterial cystitis associated with an invasive, biofilm-forming uropathogenic Escherichia coli was made with bladder-wall histology and fluorescent in situ hybridization analysis. Local treatment with EDTA-tromethamine (EDTA-Tris) infusions along with parenteral cefquinome and prophylactic measures (Type-A proanthocyanidins and probiotics) coincided with clinical and bacterial remission. The dog has been free of clinical signs of urinary tract infection for >4 y. Biofilm-forming uropathogenic E. coli can cause chronic, recurrent cystitis due to low antibiotic efficacy and should be considered in cases of recurrent cystitis in dogs, especially in the absence of identified predisposing factors. This case report describes the diagnostic and therapeutic options that were used to manage a case of this type. Key clinical message: Fluorescent in situ hybridization analysis may be considered in the diagnosis of chronic bacterial cystitis in dogs, and intravesical instillations of EDTA-Tris may be helpful in managing such cases.
Vasovagal reaction secondary to bladder overdistension in a dog undergoing a unique timeline of medical and surgical treatment for Corynebacterium urealyticum encrusting cystitis: a case report

Ryan F Peiffer,Carly Iulo,Tessa LeCuyer,Timothy Bolton

DOI: https://doi.org/10.1186/s12917-021-03028-z

2021-09-28

Abstract:Background: Corynebacterium urealyticum urinary tract infections can result in a rarely reported condition called encrusting cystitis whereby plaque lesions form on and within the urinary bladder mucosa. Chronic lower urinary tract signs manifest subsequent to the infection-induced cystitis and plaque-induced decreased bladder wall distensibility. Because of the organism's multidrug resistance and plaque forming capability, infection eradication can be difficult. While systemic antimicrobial therapy is the mainstay of treatment, adjunctive surgical debridement of plaques has been used with relative paucity in such cases, thereby limiting our understanding of this modality's indications and success rate. Consequently, this report describes the successful eradication of Corynebacterium urealyticum encrusting cystitis utilizing a unique timeline of medical and surgical treatments. Additionally, this represents the first reported veterinary case of a vasovagal reaction due to bladder overdistension. Case presentation: A 6-year-old female spayed Miniature Schnauzer was evaluated for lower urinary tract clinical signs and diagnosed with Corynebacterium urealyticum encrusting cystitis. The infection was persistent despite prolonged courses of numerous oral antimicrobials and urinary acidification. A unique treatment timeline of intravenous vancomycin, intravesical gentamicin, and mid-course surgical debridement ultimately resulted in infection resolution. During surgery, while the urinary bladder was copiously flushed and distended with saline, the dog experienced an acute vasovagal reaction from which it fully recovered. Conclusions: Surgical debridement of bladder wall plaques should be considered a viable adjunctive therapy for Corynebacterium urealyticum encrusting cystitis cases failing to respond to systemic antibiotic therapy. The timing in which surgery was employed in this case, relative to concurrent treatment modalities, may be applicable in future cases of this disease as dictated on a case-by-case basis. If surgery is ultimately pursued, overdistension of the urinary bladder should be avoided, or at least minimized as much as possible, so as to prevent the possibility of a vasovagal reaction.
Intra-abdominal nocardiosis and scedosporiosis in a dog: case report and literature review

Jessica Rose Lambert,Arthur Colombari Cheng,Laura M Lee,Donna Raiford,Emily Zuber,Erin Kilbane,Eric J Fish,Ewa Królak,Katelyn C Hlusko,Maureen McMichael,Rebecca P Wilkes,Nathan P Wiederhold,Connie F Cañete-Gibas,Daniel Felipe Barrantes Murillo

DOI: https://doi.org/10.1177/10406387241287799

2024-10-14

Abstract:A 2-y-old, intact female, mixed-breed dog was presented to the veterinary hospital with abdominal distension, anemia, and lethargy following a chronic history of nonspecific gastrointestinal signs. CBC and serum biochemistry revealed moderate nonregenerative anemia with neutrophilia, hypoalbuminemia, hyperglobulinemia, hypoglycemia, decreased urea and creatinine, and hypercholesterolemia. Abdominal radiographs and ultrasound revealed a large heterogeneous mesenteric mass and ascites. Abdominocentesis confirmed septic peritonitis with filamentous bacteria. Fine-needle aspiration of the mass yielded pyogranulomatous inflammation and hyphae. An exploratory laparotomy revealed a large cranial abdominal mass with granulomas present throughout the abdominal cavity. Due to the poor prognosis and disseminated disease, the owner elected euthanasia. Postmortem and histologic examinations detected intralesional mycetomas and bacterial colonies within the mesenteric masses. 16S ribosomal RNA gene PCR and sequencing using formalin-fixed, paraffin-embedded sections identified Nocardia yamanashiensis, Nocardioides cavernae, and Nocardioides zeicaulis. Fungal culture, PCR, and sequencing confirmed Scedosporium apiospermum. Our report highlights the importance of molecular methods in conjunction with culture and histologic findings for diagnosing coinfections caused by infrequent etiologic agents. Additionally, we provide a comprehensive literature review of Scedosporium apiospermum infections in dogs.
Abdominal cryptococcosis in dogs and cats: 38 cases (2000-2018)

L Johnston,B Mackay,T King,M B Krockenberger,R Malik,A Tebb

DOI: https://doi.org/10.1111/jsap.13232

Abstract:Introduction: To report the clinical presentation, laboratory and imaging findings, treatment and outcome of abdominal cryptococcosis in dogs and cats in Australia. Materials and methods: Canine and feline cases from Australia were retrospectively identified (2000 to 2018) via laboratory and referral centre searches for abdominal cryptococcosis diagnosed by cytology (needle aspirates) or histopathology (biopsy or necropsy) of abdominal organs/tissues. Signalment, presenting complaints, clinical signs, laboratory findings, medical imaging, latex cryptococcal antigen agglutination test (LCAT) titres, treatment and outcome data was collected. Results: Thirty-eight cases were included (35 dogs, three cats) in the study. Median age of presentation was 2 years for dogs and 6 years for cats. Common presenting complaints included vomiting (23/38), lethargy (19/38) and inappetence/anorexia (15/38). Abdominal ultrasound (25/38 cases) revealed mesenteric and intestinal lesions in most of the cases. On surgical exploration, seven cases had an intestinal lesion associated with an intussusception. Nineteen cases had a pre-treatment LCAT performed, with a median initial titre of 1:2048 (range 1:2 to 65,536). Twenty-four cases (23 dogs, one cat) received treatment, either medical, surgical or both. Median survival time for cases with combined medical and surgical treatment, surgical treatment alone or medical treatment alone was 730, 140 and 561 days, respectively. Eleven remain alive at the time of follow up. Clinical significance: Abdominal cryptococcosis although rare should be a considered as a diagnostic possibility in an especially young dog presenting with gastro-intestinal signs. Older dogs can also present with this condition and should not be euthanised based on imaging alone due to the likenesses with neoplasia. With appropriate treatment and monitoring many dogs may have a prolonged survival period and some may be cured.
Clinicopathological and diagnostic imaging findings in a dog with neurocandidiasis

Emilie Royaux,Davide Corbetta,Monika Czerwiñska,Fiona Gosling,Marie-Aude Genain

DOI: https://doi.org/10.1111/jvim.17093

Abstract:Neurocandidiasis is systemic candidiasis with central nervous system involvement. This case report describes the clinical presentation, diagnostic test results, and histopathology of a dog with neurocandidiasis. A 3-year-old German shepherd dog was presented for a 3-day history of abnormal mentation, neck pain, and ataxia. Magnetic resonance imaging (MRI) scan of the brain revealed multifocal, small, round, intra-axial lesions within the forebrain. Examination of the cerebrospinal fluid revealed severe neutrophilic inflammation. Extensive testing for infectious diseases was negative. The dog was administered immunosuppressive doses of corticosteroids. The dog's clinical signs improved transiently but got worse 12 days after starting the treatment. Repeat MRI scan revealed multiple, intra-axial, target-like nodular lesions scattered throughout the brain parenchyma. In the temporal muscles, nodules were seen. Cytology of the fine needle aspirates of the nodules in the temporal muscles revealed a neutrophilic inflammation with hyalohyphomycosis. Postmortem examination was compatible with a severe systemic fungal infection. Candida albicans was isolated from the brain, kidney, and heart.
Low-voltage high-performance silicon RF power transistors

M.P.J.G. Versleijen,R. Dekker,W. V. Einde,A. Pruijmboom

DOI: https://doi.org/10.1109/MWSYM.1995.406024

1995-05-16

Abstract:The high-frequency power performance of mounted discrete silicon bipolar transistors, that have been optimised for low-voltage application, has been evaluated. At 1.8 GHz and 3.5 V a power gain of 14 dB and a power-added efficiency of 60% at an RF power density of 1 W/mm emitter length have been measured. These results demonstrate that also at low supply voltages silicon BJTs have excellent power amplifying capabilities.<<ETX>>
Clinical analysis of caspofungin treatment for invasive fungal disease in advanced age patients

Yan-ping ZHU,Lin SHAN,Yi-nan ZHOU,Xiang-yang LI,Hui-li ZHU

DOI: https://doi.org/10.3760/cma.j.issn.0254-9026.2010.01.005

2010-01-01

Abstract:Objective To evaluate the efficacy and safety of caspofungin in the treatment of invasive fungal disease (IFD) in advanced age patients. Methods A retrospective analysis of the clinical data was conducted. IFD patients who had received caspofungin treatment in elderly wards were included. Results From January 2007 to August 2009, 29 IFD patients aged 80-100 years (mean 89 ) were treated with caspofungin. Except that one patient dead on the first drug administration day, there were 28 evaluable patients, 13 were cured (46.4%), 6 were markedly improved (21.4%), 3 progressed (10.8%) and 6 dead (21.4%). The overall effective rate was 67. 8%. Of 13cured patients, 12 were Candida bacreremia, 1 was Candida albicans disease of lung. Of 6 dead patients, 2 were Candida bacteremia, 1 was Candida albicans disease of lung and 3 was suspected of lung IFD. One patient performed that alanine aminotransferase was increased, considering drug-related impairment of liver function. Conclusions Caspofungin is effective and safe in the treatment of IFD in advanced age patients.
Successful Treatment of Cutaneous Curvularia geniculata, Nocardia niigatensis, and Viral Papillomatosis in a Dog During the Therapeutic Management of Immune-Mediated Hemolytic Anemia

Emily Strzok,Chris Siepker,Abigail Armwood,Elizabeth Howerth,Joanne Smith,Frane Banovic

DOI: https://doi.org/10.3389/fvets.2019.00249

IF: 3.471

2019-08-08

Frontiers in Veterinary Science

Abstract:Opportunistic infections represent a major cause of mortality in immunocompromised patients. Discontinuation or reduction of immunosuppressive medications is recommended with the development of opportunistic infections, which may cause a relapse or worsening of the immune-mediated disease. A 7.5-year-old, spayed female great Dane was diagnosed with immune-mediated hemolytic anemia with initial immunosuppressive therapy consisting of oral prednisone, ciclosporin and mycophenolate mofetil. The patient developed diffuse right forelimb pyogranulomatous fungal dermatitis with deep draining tracts 6 weeks into immunosuppressive treatment with Curvularia geniculata growth. Oral once daily terbinafine and itraconazole were initiated; ciclosporin was immediately discontinued and the mycophenolate mofetil/prednisone doses were reduced. The right forelimb skin lesions resolved after 4 weeks, but the patient presented with a diffuse severe neutrophilic dermatitis on the left forelimb; 16S rRNA sequencing identified Nocardia niigatensis. Cutaneous nocardiosis was treated with oral enrofloxacin and doxycycline; systemic immunosuppressive therapies were continued for immune-mediated hemolytic anemia control. One month later, the left forelimb lesions completely resolved but the patient developed several multifocal, exophytic warts; the clinical features and histopathology were consistent with viral papillomas. Within the following 4 weeks, the patient developed severe diffuse papillomatosis of the left forelimb, which was successfully treated with 2 weeks of every other day topical imiquimod administration. In this case, successful treatment of cutaneous opportunistic bacterial, fungal and viral infection was possible with proper treatment even though the immunosuppressive drug treatments could not be discontinued.

veterinary sciences
Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in A Clinical Practice Setting in China

Xiaohui Zhang,Jiong Hu,Yu Hu,He Huang,Jie Jin,Juan Li,Qifa Liu,Zonghong Shao,Jianxiang Wang,Quanshun Wang,Depei Wu,Xiaojun Huang

DOI: https://doi.org/10.1016/j.clinthera.2017.07.013

IF: 3.637

2017-01-01

Clinical Therapeutics

Abstract:PURPOSE:Invasive fungal disease (IFD) is a serious complication in patients with hematologic malignancies. Caspofungin is the first approved inhibitor of fungal β-1,3-glucan synthesis. The aim of the present study was to evaluate the effectiveness of caspofungin in the treatment of IFD in patients with hematologic malignancies.METHODS:In this retrospective study, data from the electronic medical records of 1118 inpatients who were admitted to 10 hospitals in China between 2013 and 2014 were analyzed. Inclusion criteria were hematologic disorder and IFD diagnosed during the hospitalization, based on clinical manifestations or evidence of pulmonary invasion, as well as caspofungin treatment for at least 7 days. The primary end point was the favorable response rate at the end of caspofungin as initial therapy for proven/probable/possible pulmonary IFD. The secondary end point was the survival rate after the completion of the caspofungin treatments.FINDINGS:A total of 704 patients were included, of whom 122 had IFD classified as probable/possible and 582 had unclassified IFD. The most frequent hematologic diseases were acute myeloid leukemia (42.8%), followed by acute lymphatic leukemia (18.8%), non-Hodgkin lymphoma (8.8%), aplastic anemia (7.1%), and others (22.5%). The rates of favorable caspofungin response were 57.2% in all patients, 58.2% in the probable/possible IFD group, and 57.0% in the unclassified IFD group. Caspofungin as initial monotherapy led to a favorable response rate of 62.2% in the probable/possible IFD group. Uni- and multivariate analyses revealed that not recovering from neutropenia during antifungal treatment, and advanced age, were significant factors for unfavorable outcomes. The overall IFD-related mortality rate was 4.1%.IMPLICATIONS:The results of our study show that caspofungin treatment of IFD in hematology patients was reasonable, with an overall rate of favorable response of 57.2% with each caspofungin treatment strategy.
Clinical study of caspofungin for the treatment of invasive fungal disease

Guangfa ZHU,Shuang LIU,Wei ZHANG,Jinghua YANG,Yuhong MI,Jinglan ZHANG,Xiangfeng ZHANG,Zeying LIU,Yanhui LU,Ying ZHANG,Hua ZONG

DOI: https://doi.org/10.16718/j.1009-7708.2011.05.013

2011-01-01

Abstract:Objective To evaluate the efficacy and safety of caspofungin for the treatment of invasive fungal disease(IFD) in intensive care unit(1CU) patients.Methods The clinical data of IFD patients who were treated with caspofungin in 3 ICUs(respiratory, emergency and surgical) were retrospectively reviewed and analyzed.Results From May 2005 to November 2009,35 patients with IFD were treated with caspofungin,including 24 males and 11 females.The mean age was(58.3±24.1) years old.Twenty were proven cases,including 18 candidemia(10 C.albicans,3 C.parapsilosis,2 C.glabrata,2 C.tropicalis and 1 C.krusei),2 cases of pulmonary IFD(1 C.glabrata and 1 Aspergillus),5 probable pulmonary IFD cases and 10 possible pulmonary IFD cases.Twenty-five patients were post-operational(20 cardiovascular,5 others).The remaining 10 were internal medicine patients(4 with connective tissue disease,3 chronic pulmonary diseases and 1 adult Still's disease receiving long term steroid therapy,2 lung cancer receiving chemotherapy).The mean duration of the caspofungin therapy was(19.8±11.3) days.Among the 34 evaluable patients(1 died of cardiac arrest within 24 hours after the therapy and was excluded),16 were cured(16/34,47.1%),9 were markedly improved(9/34,26.5%).The overall effective rate was 73.6%(25/34).Five patients were improved and 4 failed.Thirteen patients died finally.The overall mortality rate was 37.1%(13/35).No drug-related side effect or toxicity was recorded.Conclusions Caspofungin may be an effective and safe drug to treat IFD in ICU patients, which warrants further clinical study.
Inhibition and affinity chromatography of human serum angiotensin converting enzyme with cysteinyl-proline derivatives.

R. Harris,J. Ohlsson,I. Wilson

DOI: https://doi.org/10.1016/0003-9861(81)90071-0

IF: 4.114

Archives of Biochemistry and Biophysics

Abstract:
Case Report: Oral Fecal Microbiota Transplantation in a Dog Suffering From Relapsing Chronic Diarrhea—Clinical Outcome and Follow-Up

Matteo Cerquetella,Andrea Marchegiani,Giacomo Rossi,Massimo Trabalza-Marinucci,Fabrizio Passamonti,Marco Isidori,Fabrizio Rueca

DOI: https://doi.org/10.3389/fvets.2022.893342

IF: 3.471

2022-07-04

Frontiers in Veterinary Science

Abstract:The present case report describes the effects of orally administered fecal microbiota transplantation (FMT) (frozen capsules) in a dog suffering from relapsing chronic diarrhea, needing a continuous low prednisolone dose to maintain the condition under acceptable control. Through FMT, we aimed at evaluating the possibility of improving the clinical score and/or reducing/suspending steroid administration. During a first period of strict monitoring (21 days), the canine inflammatory bowel disease activity index (CIBDAI) score passed from mild to clinically insignificant disease. Furthermore, two additional gastrointestinal signs that had been reported, bloating and episodes of painful defecation, rapidly improved (bloating) or even resolved (painful defecation). The patient was then followed for 18 months (to the authors' knowledge, the longest follow-up time ever reported in a dog), during which no serious relapses occurred and no increase in prednisolone dose was necessary. No adverse clinical effects were ever reported during monitoring. The present description provides a further experience increasing those already present in the veterinary literature, in which an agreement on how to use FMT has not yet been achieved although strongly needed and recommended.

veterinary sciences
Candida auris detected in the oral cavity of a dog in Kansas

Theodore C. White,Brooke D. Esquivel,Elisa M. Rouse Salcido,Allison M. Schweiker,Amanda R. dos Santos,Lalitha Gade,Erin Petro,Butch KuKanich,Kate S. KuKanich

DOI: https://doi.org/10.1128/mbio.03080-23

IF: 6.4

2024-01-10

mBio

Abstract:ABSTRACT Candida auris is an emerging human fungal pathogen, first described in Japan in 2009, and first detected in the United States in 2016. Here, we report the first-ever description of C. auris colonizing a human pet, the first identification of C. auris in a non-human mammal in the United States and the first C. auris isolate from the state of Kansa. While analyzing the oral mycobiome of dogs from a shelter in Kansas, the oral swab from one dog was found to contain C. auris as well as three other fungal species. The presence of C. auris in a dog suggests the possibility of zoonotic transmission to humans. The isolate is a member of Clade IV, which has been found in patients in Chicago and Florida, while Clades I and III are the most prevalent in the United States. The isolate is resistant to fluconazole, terbinafine, and amphotericin B but susceptible to caspofungin, consistent with the drug-resistant characteristics of many human C. auris isolates. The source of C. auris transient colonization in this dog is unknown, and there is no evidence that it was further transmitted to humans, other dogs in the shelter, or pets in its adopted household. Isolation of C. auris from a dog in Kansas has public health implications as a potential emerging source for the zoonotic spread of this pathogenic fungus, and for the development of antifungal resistance. IMPORTANCE Candida auris is an emerging fungal infection of humans and is particularly problematic because it is multi-drug resistant and difficult to treat. It is also known to be spread from person to person by contact and can remain on surfaces for long periods of time. In this report, a dog in a shelter in Kansas is found to be colonized with Candida auris . This is the first study to document the presence of Candida auris on a pet, the first to document C. auris presence on a non-human mammal in the United States, and the first to report an isolate of C. auris within the state of Kansas. The presence of C. auris in a pet dog raises the possibility of zoonotic transmission from pets to human or vice versa.

microbiology
Treatment of invasive fungal disease: A case report

Xue-Fei Xiao,Jiong-Xing Wu,Yang-Cheng Xu

DOI: https://doi.org/10.12998/wjcc.v7.i16.2374

2019-08-26

Abstract:Background: In recent years, the incidence of fungal infection has been increasing, often invading one or more systems of the body. However, it is rare for lymph nodes to be invaded without the involvement of other organs. Case summary: A 21-year-old man was admitted to hospital for repeated cough for 2 mo and abdominal pain for 1 mo. Physical examination revealed multiple lymph nodes enlargement, especially those in the left neck and groin. CT scan showed multiple lymph nodes enlargement in the chest, especially left lung, abdominal cavity, and retroperitoneum. The first lymph node biopsy revealed granulomatous lesions of lymph nodes, so intravenous infusion of Cefoperazone tazobactam combined with anti-tuberculosis drugs were given. Because fever and respiratory failure occurred 4 d after admission, mechanical ventilation was given, and Caspofungin and Voriconazole were used successively. However, the disease still could not be controlled. On the 11th day of admission, the body temperature reached 40° C. After mycosis of lymph nodes was confirmed by the second lymph node biopsy, Amphotericin B was given, and the patient recovered and was discharged from the hospital. Conclusion: No fixed target organ was identified in this case, and only lymph node involvement was found. Caspofungin, a new antifungal drug, and the conventional first choice drug, Voriconazole, were ineffective, while Amphotericin B was effective.
[Responses of subalpine meadow Poa botryoides to climate change].

Yu-bi Yao,Xiu-yun Zhang,Run-yuan Wang,Hua-Yin An

2009-02-01

Abstract:Based on the field plot observation and related meteorological data, the effects of climate change in 1985-2005 on the growth and development of subalpine meadow Poa botryoides in Maqu County of Gansu Province were analyzed. The results showed that during study period, the annual precipitation in the Maqu County had a decreasing trend, with a rate of -9.895 mm x (10 a)(-1) and a cycle of 3 years, while the annual air temperature had an increasing trend, with a rate of 0.341 degrees C x (10 a)(-1). The aridity index of P. botryoides in growth season had an obvious increasing trend, with a rate of 0.036 x (10 a)(-1), and the tendency was more markedly from the beginning of the 1990s to 2005. The period from reviving to ripeness of P. botryoides was 140-150 d, and the requirements of accumulated temperature above 0 degree C, precipitation, and sunshine duration in this period were 1000 degrees C-1200 degrees C, 400-450 mm, and 1000-1100 h, respectively. The growth rate of P. botryoides turned to higher at 54 d after reviving, reached the highest at 80 d after reviving, and became lower at 104 d after reviving. Under the effects of climate warming, the phenophase of P. botryoides was advanced by 15 d x (10 a)(-1) at heading stage, 7-8 d x (10 a)(-1) at flowering stage, 8-9 d x (10 a)(-1) at ripeness stage, and 3 d x (10 a)(-1) at withering stage. Climate change made the P. botryoides yield in study area have greater variation and higher unsteadiness.
Uroprotective and pain-relieving effect of dietary supplementation with micronized palmitoyl-glucosamine and hesperidin in a chronic model of cyclophosphamide-induced cystitis

Enrico Gugliandolo,Gianluca Antonio Franco,Ylenia Marino,Alessio Filippo Peritore,Daniela Impellizzeri,Marika Cordaro,Rosalba Siracusa,Roberta Fusco,Ramona D'Amico,Francesco Macrì,Rosanna Di Paola,Salvatore Cuzzocrea,Rosalia Crupi

DOI: https://doi.org/10.3389/fvets.2023.1327102

2024-01-04

Abstract:Introduction: Feline idiopathic cystitis is a common, chronic-relapsing disorder of the lower urinary tract. In addition to environmental modification/enrichment, long-term and safe treatment targeting specific pathophysiological changes may be of help. In this context, effective dietary interventions hold clinical promise. Palmitoyl-glucosamine (PGA) and hesperidin (HSP) are safe and authorized feed ingredients for animal nutrition under European regulations. Methods: The current study aimed to investigate whether a 3:1 mixture of micronized PGA and HSP could represent a novel mechanism-oriented approach to chronic cystitis management. A newly validated rat model of cyclophosphamide (CYP)-induced chronic cystitis was used (40 mg/kg, three intraperitoneal injections every 3rd day). Animals were randomized to orally receive either vehicle or PGA-HSP at a low (72 + 24 mg/kg) or high (doubled) dose for 13 days, starting 3 days before the chronic CYP protocol, with mesna (2-mercaptoethane-sulfonate) being used as a reference drug. Results: Higher PGA-HSP dose was effective at relieving chronic visceral pain, as measured by mechanical allodynia test (von Frey test). The severity of cystitis was also significantly improved, as shown by the reduced sonographic thickening of the bladder wall, as well as the decrease in edema, bleeding and bladder to body weight ratio compared to the vehicle treated group. A significant decrease of MPO activity, MDA level and fibrosis at Masson's trichrome staining was also observed in animals administered PGA-HSP in comparison to vehicle treated ones. The CYP-induced increase in bladder mRNA expression of pro-inflammatory cytokines was also significantly counteracted by the study mixture. Moreover, CYP-induced bladder mast cell accumulation and releasability were significantly decreased by PGA-HSP (even at the low dose), as determined by metachromatic staining, chymase and tryptase immunostaining as well as enzyme-linked immunosorbent assay for histamine and 5-hydoxytriptamine. Discussion: PGA-HSP is able to block CYP-induced decrease of tight junction proteins, claudin-1 and occludin, thus preserving the urothelial bladder function. Finally, neuroinflammatory changes were investigated, showing that dietary supplementation with PGA-HSP prevented the activation of neurons and non-neuronal cells (i.e., microglia, astrocytes and mast cells) at the spinal level, and counteracted CYP-induced increase of spinal mRNA encoding for pro-inflammatory cytokines. Altogether, the present findings confirm the uroprotective and pain-relieving effect of PGA-HSP and pave the way to potential and relevant clinical applications of the study supplement in feline idiopathic cystitis.
Case report: Emphysematous cystitis due to Escherichia coli infection with the extension of gas into multiple locations in two non-diabetic dogs: a computed tomographic diagnosis and successful management

Eun-Ji Lee,Jeong-Min Lee,Jin-Young Kim,Tae-Sung Hwang,Kun-Ho Song,Joong-Hyun Song

DOI: https://doi.org/10.3389/fvets.2023.1196006

2023-07-14

Abstract:Emphysematous cystitis is an extremely rare, complicated urinary tract infection with the presence of gas in the bladder wall and lumen caused by gas-producing bacterial infections. A 7-year-old spayed female pomeranian dog was presented with a 3-day history of hematuria and pollakiuria (case 1), and a 9-year-old spayed female jindo dog was presented with a 4-day history of intermittent hematuria (case 2). Imaging modalities, including radiography, ultrasonography, and computed tomography, and bacterial culture tests were used for the diagnosis. Emphysematous cystitis due to Escherichia coli infection with the extension of gas into multiple locations was identified in both cases. Based on the results of antibiotic susceptibility testing, systemic antibiotics were initiated. Both animals had an excellent response to antibiotic treatment, and the clinical signs of the gas collection were completely resolved within ~1 month after treatment initiation. This response was sustained without recurrence in the follow-up period. This case report describes clinical details of extremely rare canine cases of emphysematous cystitis with the extension of gas into multiple locations and evaluates the clinical efficacy of antibiotic therapy.
Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China.

Xiaohui Zhang,Jiong Hu,Yu Hu,He Huang,Jie Jin,Juan Li,Qifa Liu,Zonghong Shao,Jianxiang Wang,Quanshun Wang,Depei Wu,Xiaojun Huang

DOI: https://doi.org/10.12659/msm.908831

2018-01-01

Medical Science Monitor

Abstract:BACKGROUND The management of invasive fungal infection (IFI) is challenging in immunocompromised patients who do not fully satisfy the EORTC/MSG diagnostic criteria of proven or probable IFI. Our study assessed caspofungin efficacy in 582 Chinese patients with hematological malignancies exhibiting unclassified signs or symptoms of IFI. MATERIAL AND METHODS This retrospective study included caspofungin treatment outcomes of an unclassified group A (n=401) of patients without microbiological or biomarker results and group B (n=181) patients with positive microbiological or biomarker results. Factors that correlated with clinical outcomes were determined using univariate and multivariate analyses. RESULTS Cough (41.8%), expectoration (29.6%), and chest tightness (14.6%) were the most common clinical features, and changes in CT images (88.1%) were more frequently detected than in X-ray images (19.6%) in all patients. Favorable response rates for caspofungin as first-line treatment were 58.2% for group A and 56.3% for group B. Eastern Cooperative Oncology Group (ECOG) score, cardiovascular disease, hemoptysis, and absolute neutrophil count (ANC) <1000/mm³ before antifungal treatment without recovery were associated with unfavorable clinical outcome (P<0.05 for all). Cough and ANC recovery >1000/mm3 were significantly associated with favorable (complete or partial resolution) outcome. CONCLUSIONS Caspofungin was effective for treating unclassified IFIs of immunocompromised patients. Cardiovascular disease, ECOG score, cough, and/or hemoptysis, as well as ANC count, represent a potential index for estimating response of unclassified IFI patients to caspofungin treatments.

Calcium-dependent Enhancement of Depletion-activated Calcium Current in Jurkat T Lymphocytes

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

Fungus Ball and Emphysematous Cystitis Secondary to Candida Tropicalis: A Case Report

Adjunctive intravesical EDTA-tromethamine treatment of a biofilm-associated recurrent Escherichia coli cystitis in a dog

Vasovagal reaction secondary to bladder overdistension in a dog undergoing a unique timeline of medical and surgical treatment for Corynebacterium urealyticum encrusting cystitis: a case report

Intra-abdominal nocardiosis and scedosporiosis in a dog: case report and literature review

Abdominal cryptococcosis in dogs and cats: 38 cases (2000-2018)

Clinicopathological and diagnostic imaging findings in a dog with neurocandidiasis

Low-voltage high-performance silicon RF power transistors

Clinical analysis of caspofungin treatment for invasive fungal disease in advanced age patients

Successful Treatment of Cutaneous Curvularia geniculata, Nocardia niigatensis, and Viral Papillomatosis in a Dog During the Therapeutic Management of Immune-Mediated Hemolytic Anemia

Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in A Clinical Practice Setting in China

Clinical study of caspofungin for the treatment of invasive fungal disease

Inhibition and affinity chromatography of human serum angiotensin converting enzyme with cysteinyl-proline derivatives.

Case Report: Oral Fecal Microbiota Transplantation in a Dog Suffering From Relapsing Chronic Diarrhea—Clinical Outcome and Follow-Up

Candida auris detected in the oral cavity of a dog in Kansas

Treatment of invasive fungal disease: A case report

[Responses of subalpine meadow Poa botryoides to climate change].

Uroprotective and pain-relieving effect of dietary supplementation with micronized palmitoyl-glucosamine and hesperidin in a chronic model of cyclophosphamide-induced cystitis

Case report: Emphysematous cystitis due to Escherichia coli infection with the extension of gas into multiple locations in two non-diabetic dogs: a computed tomographic diagnosis and successful management

Efficacy of Caspofungin in Unclassified Invasive Fungal Infection Cases: A Retrospective Analysis of Patients with Hematological Malignancies in China.